Left ventricular assist device for ventricular recovery of anabolic steroid-induced cardiomyopathy. Issue 8 (15th August 2018)

• Record Type: Journal Article
• Authors: Luc, Jessica G Y; Buchholz, Holger; Kim, Daniel H; MacArthur, Roderick G G
• Is Part Of: Journal of surgical case reports. Issue 8(2018)
• Publication Date: 2018-08-15
• Subjects: Surgery -- Periodicals; Surgery -- Case studies -- Periodicals; 617.005
• DOI: 10.1093/jscr/rjy221
• Languages: English
• ISSNs: 2042-8812

Abstract

Abstract: Herein we report a case of a 26-year-old gentleman with severe cardiomyopathy likely secondary to anabolic-androgenic steroid (AAS) abuse who received a HeartMate II (Abbott Laboratories, Abbott Park, IL) left ventricular assist device (LVAD) for rapidly deteriorating heart failure with hemodynamic compromise. Following 18 months on LVAD support, excellent recovery of ventricular function was achieved to allow for LVAD discontinuation. Given that active substance abuse is a contraindication to heart transplantation, few options remain for patients with AAS induced heart failure. Our case demonstrates that LVAD therapy can be an important intervention for bridging to candidacy, recovery or destination therapy.